A Comparative Study on The Safety and Efficacy Of Intrathecal 0.5% Hyperbaric Bupivacaine Alone Versus Bupivacaine Along With Adjuvant Dexmedetomidine In Parturient Undergoing Cesarean Section – A Prospective Observational Study
International Journal of Community Pharmacy · 30.03.2023 · 32-39
DOI: 10.65301/ijcp.2023.1.4.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Community Pharmacy, online erschienen am 30.03.2023. Verfasst von Affifa Maqbool Hussain und 5 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
AIM: The aim of this study is to assess the efficacy and safety of 0.5% hyperbaric bupivacaine administered alone versus when given along with adjuvant dexmedetomidine in parturients undergoing LSCS. METHOD: A hundred parturients of ASA grade II & III undergoing LSCS under spinal anaesthesia were randomly assigned into two groups of 50 each. group B received 0.5% hyperbaric bupivacaine (2ml) and group BD received 0.5% hyperbaric bupivacaine (1.9ml) with 10 mcg of dexmedetomidine (0.1ml). The onset and duration of sensory & motor block, intraoperative hemodynamic changes, and duration of analgesia CONCLUSION: The findings of this study indicate that 10 mcg dexmedetomidine is more beneficial when used in conjunction with 0.5% hyperbaric bupivacaine compared to 0.5% hyperbaric bupivacaine used alone in parturients undergoing C-section under spinal anesthesia.
Zitieren
APA
Hussain, A. M., M, U., ML, K., Rambia, R. N., K, S., & Josh, H. (2023). A Comparative Study on The Safety and Efficacy Of Intrathecal 0.5% Hyperbaric Bupivacaine Alone Versus Bupivacaine Along With Adjuvant Dexmedetomidine In Parturient Undergoing Cesarean Section – A Prospective Observational Study. International Journal of Community Pharmacy, 32-39. https://doi.org/10.65301/ijcp.2023.1.4.4
Vancouver
Hussain AM, M U, ML K, Rambia RN, K S, Josh H. A Comparative Study on The Safety and Efficacy Of Intrathecal 0.5% Hyperbaric Bupivacaine Alone Versus Bupivacaine Along With Adjuvant Dexmedetomidine In Parturient Undergoing Cesarean Section – A Prospective Observational Study. International Journal of Community Pharmacy. 2023:32-39. doi:10.65301/ijcp.2023.1.4.4
BibTeX
@article{Hussain2023,
author = {Hussain, Affifa Maqbool and M, Umesh and ML, Kavya and Rambia, Rushali Nimesh and K, Santhya and Josh, Hanumanthachar},
title = {A Comparative Study on The Safety and Efficacy Of Intrathecal 0.5% Hyperbaric Bupivacaine Alone Versus Bupivacaine Along With Adjuvant Dexmedetomidine In Parturient Undergoing Cesarean Section – A Prospective Observational Study},
journal = {International Journal of Community Pharmacy},
year = {2023},
pages = {32--39},
doi = {10.65301/ijcp.2023.1.4.4}
}
EUVIMED